{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:20:09Z","timestamp":1788607209881,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T00:00:00Z","timestamp":1646438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is a neurodegenerative disorder and is the most common cause of late-onset dementia. Microglia, the primary innate immune cells of the central nervous system (CNS), have a complex role in AD neuropathology. In the initial stages of AD, microglia play a role in limiting pathology by removing amyloid-\u03b2 (A\u03b2) by phagocytosis. In contrast, microglia also release pro-inflammatory cytokines and chemokines to promote neuroinflammation and exacerbate AD neuropathology. Therefore, investigating microglial gene networks could identify new targets for therapeutic strategies for AD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 465 differentially expressed genes (DEG) in 5XFAD versus wild-type mice by microarray, 354 DEG in lipopolysaccharide (LPS)-stimulated N9 microglia versus unstimulated control cells using RNA-sequencing (RNA-seq), with 32 DEG common between both datasets. Analyses of the 32 common DEG uncovered numerous molecular functions and pathways involved in A\u03b2 phagocytosis and neuroinflammation associated with AD. Furthermore, multiplex ELISA confirmed the induction of several cytokines and chemokines in LPS-stimulated microglia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In summary, AD triggered multiple signaling pathways that regulate numerous genes in microglia, contributing to A\u03b2 phagocytosis and neuroinflammation. Overall, these data identified several regulatory factors and biomarkers in microglia that could be useful in further understanding AD neuropathology.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12864-022-08417-8","type":"journal-article","created":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T23:02:18Z","timestamp":1646521338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Transcriptional response of murine microglia in Alzheimer\u2019s disease and inflammation"],"prefix":"10.1186","volume":"23","author":[{"given":"Daniel C.","family":"Shippy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti J.","family":"Watters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler K.","family":"Ulland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,5]]},"reference":[{"key":"8417_CR1","doi-asserted-by":"crossref","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327\u2013406.","DOI":"10.1002\/alz.12328"},{"issue":"77","key":"8417_CR2","doi-asserted-by":"publisher","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, Morris JC, Goate AM. Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med. 2011;3(77):77sr71.","journal-title":"Sci Transl Med"},{"issue":"3","key":"8417_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"8417_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00227813","volume":"84","author":"J Frackowiak","year":"1992","unstructured":"Frackowiak J, Wisniewski HM, Wegiel J, Merz GS, Iqbal K, Wang KC. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol. 1992;84(3):225\u201333.","journal-title":"Acta Neuropathol"},{"key":"8417_CR5","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J. Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nat Commun. 2015;6:6176.","journal-title":"Nat Commun"},{"issue":"10","key":"8417_CR6","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3(10):136.","journal-title":"Ann Transl Med"},{"issue":"4","key":"8417_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell. 2017;170(4):649-663 e613.","journal-title":"Cell"},{"issue":"4","key":"8417_CR8","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, Ulland TK, Mahan TE, Nystrom S, Nilsson KP, Song WM, Zhou Y, Reinartz M, Choi S, Jiang H, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215(4):1047\u201358.","journal-title":"J Exp Med"},{"issue":"40","key":"8417_CR9","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340.","journal-title":"J Neurosci"},{"issue":"6","key":"8417_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160(6):1061\u201371.","journal-title":"Cell"},{"issue":"1","key":"8417_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat Med. 2020;26(1):131\u201342.","journal-title":"Nat Med"},{"issue":"7","key":"8417_CR12","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169(7):1276-1290 e1217.","journal-title":"Cell"},{"issue":"3","key":"8417_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019Loughlin E, Xu Y, Fanek Z, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566-581 e569.","journal-title":"Immunity"},{"issue":"1","key":"8417_CR14","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/s41467-021-23111-1","volume":"12","author":"A Grubman","year":"2021","unstructured":"Grubman A, Choo XY, Chew G, Ouyang JF, Sun G, Croft NP, Rossello FJ, Simmons R, Buckberry S, Landin DV, et al. Transcriptional signature in microglia associated with Abeta plaque phagocytosis. Nat Commun. 2021;12(1):3015.","journal-title":"Nat Commun"},{"issue":"1","key":"8417_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-018-0296-y","volume":"13","author":"H Wang","year":"2018","unstructured":"Wang H, Li Y, Ryder JW, Hole JT, Ebert PJ, Airey DC, Qian HR, Logsdon B, Fisher A, Ahmed Z, et al. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model. Mol Neurodegener. 2018;13(1):65.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"8417_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","volume":"30","author":"SH Baik","year":"2019","unstructured":"Baik SH, Kang S, Lee W, Choi H, Chung S, Kim JI, Mook-Jung I. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer\u2019s Disease. Cell Metab. 2019;30(3):493-507 e496.","journal-title":"Cell Metab"},{"issue":"4","key":"8417_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"7434","key":"8417_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493(7434):674\u20138.","journal-title":"Nature"},{"issue":"1","key":"8417_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","volume":"17","author":"DC Shippy","year":"2020","unstructured":"Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK. beta-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer\u2019s disease pathology. J Neuroinflammation. 2020;17(1):280.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"8417_CR20","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","volume":"18","author":"EL Goldberg","year":"2017","unstructured":"Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C, Morozova-Roche LA, Herzog RI, Iwasaki A, Dixit VD. beta-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares. Cell Rep. 2017;18(9):2077\u201387.","journal-title":"Cell Rep"},{"issue":"3","key":"8417_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D\u2019Agostino D, Planavsky N, Lupfer C, Kanneganti TD, et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139.","journal-title":"Nat Med"},{"issue":"6","key":"8417_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/jmg.40.6.424","volume":"40","author":"JC Lambert","year":"2003","unstructured":"Lambert JC, Luedecking-Zimmer E, Merrot S, Hayes A, Thaker U, Desai P, Houzet A, Hermant X, Cottel D, Pritchard A, et al. Association of 3\u2019-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer\u2019s disease. J Med Genet. 2003;40(6):424\u201330.","journal-title":"J Med Genet"},{"issue":"10","key":"8417_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.21037\/atm.2018.04.31","volume":"6","author":"ZT Wang","year":"2018","unstructured":"Wang ZT, Zhong XL, Tan MS, Wang HF, Tan CC, Zhang W, Zheng ZJ, Kong LL, Tan L, Sun L. Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese. Ann Transl Med. 2018;6(10):172.","journal-title":"Ann Transl Med"},{"issue":"4\u20135","key":"8417_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00439-002-0802-7","volume":"111","author":"E Luedecking-Zimmer","year":"2002","unstructured":"Luedecking-Zimmer E, DeKosky ST, Chen Q, Barmada MM, Kamboh MI. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer\u2019s disease on chromosome 12. Hum Genet. 2002;111(4\u20135):443\u201351.","journal-title":"Hum Genet"},{"issue":"4","key":"8417_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-2009-0976","volume":"16","author":"I Granic","year":"2009","unstructured":"Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. Inflammation and NF-kappaB in Alzheimer\u2019s disease and diabetes. J Alzheimers Dis. 2009;16(4):809\u201321.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"8417_CR26","first-page":"463","volume":"10","author":"M Ujiie","year":"2003","unstructured":"Ujiie M, Dickstein DL, Carlow DA, Jefferies WA. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation. 2003;10(6):463\u201370.","journal-title":"Microcirculation"},{"issue":"9A","key":"8417_CR27","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","volume":"13","author":"JK Ryu","year":"2009","unstructured":"Ryu JK, McLarnon JG. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer\u2019s disease brain. J Cell Mol Med. 2009;13(9A):2911\u201325.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"8417_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","volume":"1","author":"R Mayeux","year":"2004","unstructured":"Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. 2004;1(2):182\u20138.","journal-title":"NeuroRx"},{"issue":"18","key":"8417_CR29","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1073\/pnas.91.18.8368","volume":"91","author":"AL Schwarzman","year":"1994","unstructured":"Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK, et al. Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A. 1994;91(18):8368\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8417_CR30","doi-asserted-by":"publisher","first-page":"20164","DOI":"10.1038\/srep20164","volume":"6","author":"M Alemi","year":"2016","unstructured":"Alemi M, Gaiteiro C, Ribeiro CA, Santos LM, Gomes JR, Oliveira SM, Couraud PO, Weksler B, Romero I, Saraiva MJ, et al. Transthyretin participates in beta-amyloid transport from the brain to the liver\u2013involvement of the low-density lipoprotein receptor-related protein 1? Sci Rep. 2016;6:20164.","journal-title":"Sci Rep"},{"issue":"12","key":"8417_CR31","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.bbadis.2013.09.011","volume":"1832","author":"R Cascella","year":"2013","unstructured":"Cascella R, Conti S, Mannini B, Li X, Buxbaum JN, Tiribilli B, Chiti F, Cecchi C. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Biochim Biophys Acta. 2013;1832(12):2302\u201314.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"8417_CR32","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.febslet.2008.02.034","volume":"582","author":"R Costa","year":"2008","unstructured":"Costa R, Goncalves A, Saraiva MJ, Cardoso I. Transthyretin binding to A-Beta peptide\u2013impact on A-Beta fibrillogenesis and toxicity. FEBS Lett. 2008;582(6):936\u201342.","journal-title":"FEBS Lett"},{"issue":"50","key":"8417_CR33","doi-asserted-by":"publisher","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","volume":"33","author":"X Li","year":"2013","unstructured":"Li X, Zhang X, Ladiwala AR, Du D, Yadav JK, Tessier PM, Wright PE, Kelly JW, Buxbaum JN. Mechanisms of transthyretin inhibition of beta-amyloid aggregation in vitro. J Neurosci. 2013;33(50):19423\u201333.","journal-title":"J Neurosci"},{"issue":"17","key":"8417_CR34","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.jmb.2018.06.005","volume":"430","author":"L Nilsson","year":"2018","unstructured":"Nilsson L, Pamren A, Islam T, Brannstrom K, Golchin SA, Pettersson N, Iakovleva I, Sandblad L, Gharibyan AL, Olofsson A. Transthyretin Interferes with Abeta Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates. J Mol Biol. 2018;430(17):2722\u201333.","journal-title":"J Mol Biol"},{"issue":"4","key":"8417_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/jnnp.63.4.506","volume":"63","author":"JM Serot","year":"1997","unstructured":"Serot JM, Christmann D, Dubost T, Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;63(4):506\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"8417_CR36","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2174\/156720512803251057","volume":"9","author":"CA Ribeiro","year":"2012","unstructured":"Ribeiro CA, Santana I, Oliveira C, Baldeiras I, Moreira J, Saraiva MJ, Cardoso I. Transthyretin decrease in plasma of MCI and AD patients: investigation of mechanisms for disease modulation. Curr Alzheimer Res. 2012;9(8):881\u20139.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"8417_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JAD-2011-102145","volume":"25","author":"SH Han","year":"2011","unstructured":"Han SH, Jung ES, Sohn JH, Hong HJ, Hong HS, Kim JW, Na DL, Kim M, Kim H, Ha HJ, et al. Human serum transthyretin levels correlate inversely with Alzheimer\u2019s disease. J Alzheimers Dis. 2011;25(1):77\u201384.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"8417_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2011-110611","volume":"28","author":"L Velayudhan","year":"2012","unstructured":"Velayudhan L, Killick R, Hye A, Kinsey A, Guntert A, Lynham S, Ward M, Leung R, Lourdusamy A, To AW, et al. Plasma transthyretin as a candidate marker for Alzheimer\u2019s disease. J Alzheimers Dis. 2012;28(2):369\u201375.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"8417_CR39","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JAD-150183","volume":"47","author":"MA Bradley-Whitman","year":"2015","unstructured":"Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA. A Novel Plasma Based Biomarker of Alzheimer\u2019s Disease. J Alzheimers Dis. 2015;47(3):761\u201371.","journal-title":"J Alzheimers Dis"},{"key":"8417_CR40","doi-asserted-by":"crossref","unstructured":"Consensus report of the Working Group on: \"Molecular and Biochemical Markers of Alzheimer's Disease\". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiol Aging.\u00a01998;19(2):109\u201316.","DOI":"10.1016\/S0197-4580(98)00022-0"},{"issue":"9","key":"8417_CR41","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127(9):3240\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"8417_CR42","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, Cimpean M, Khairallah A, Coronas-Samano G, Sankowski R, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat Commun. 2020;11(1):6129.","journal-title":"Nat Commun"},{"issue":"2","key":"8417_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T. Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol. 2017;133(2):155\u201375.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"8417_CR44","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3233\/JAD-161027","volume":"56","author":"P Liu","year":"2017","unstructured":"Liu P, Reichl JH, Rao ER, McNellis BM, Huang ES, Hemmy LS, Forster CL, Kuskowski MA, Borchelt DR, Vassar R, et al. Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-beta Protein Precursor Transgenic Mice. J Alzheimers Dis. 2017;56(2):743\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"8417_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01099-x","volume":"9","author":"A Sobue","year":"2021","unstructured":"Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, Murayama S, Saito T, Saido TC, Sahara N, et al. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9(1):1.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"8417_CR46","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/eji.1830190815","volume":"19","author":"M Righi","year":"1989","unstructured":"Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur J Immunol. 1989;19(8):1443\u20138.","journal-title":"Eur J Immunol"},{"key":"8417_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuroscience.2011.06.006","volume":"190","author":"M Nikodemova","year":"2011","unstructured":"Nikodemova M, Watters JJ. Outbred ICR\/CD1 mice display more severe neuroinflammation mediated by microglial TLR4\/CD14 activation than inbred C57Bl\/6 mice. Neuroscience. 2011;190:67\u201374.","journal-title":"Neuroscience"},{"key":"8417_CR48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1742-2094-9-115","volume":"9","author":"B Stansley","year":"2012","unstructured":"Stansley B, Post J, Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer\u2019s disease. J Neuroinflammation. 2012;9:115.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"8417_CR49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J R Stat Soc B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc B"},{"issue":"1","key":"8417_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"issue":"1","key":"8417_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"8417_CR52","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"8417_CR53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16:169.","journal-title":"BMC Bioinformatics"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-022-08417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-022-08417-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-022-08417-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:42:02Z","timestamp":1726778522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-022-08417-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,5]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8417"],"URL":"https:\/\/doi.org\/10.1186\/s12864-022-08417-8","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,5]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant local and University of Wisconsin guidelines and regulations. All animals were handled in accordance with the Animal Research: Reporting of in vivo Experiments (ARRIVE) guidelines and the University of Wisconsin\u2019s Institutional Animal Care and Use Committee policies and our approved protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}